Targeting Upr mechanism by dasatinib as a promising therapeutic approach in chronic myeloid leukemia

Ozel, B.Kipcak, S.Avci, C. BirayGunduz, C.Gunel, N. Selvi2019-10-272019-10-2720171742-464X1742-4658https://hdl.handle.net/11454/3173142nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back -- SEP 10-14, 2017 -- Jerusalem, ISRAELeninfo:eu-repo/semantics/closedAccessTargeting Upr mechanism by dasatinib as a promising therapeutic approach in chronic myeloid leukemiaConference Object284272272WOS:000409918903219Q1